Clinical Trial Update: The MIND Study: Modifying the INcidence of Delirium [Phase 2]

View source ↗

Summary

The MIND study, a Phase 2 trial evaluating strategies to modify the incidence of delirium, has completed enrollment and status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorders
• Delirium

Snippet

Sponsor: Vanderbilt University | Conditions: Delirium, Cognition Disorders | Phase 2 | Status: COMPLETED